These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 31016348)

  • 1. Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms.
    Oksanen M; Lehtonen S; Jaronen M; Goldsteins G; Hämäläinen RH; Koistinaho J
    Cell Mol Life Sci; 2019 Jul; 76(14):2739-2760. PubMed ID: 31016348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Astrocytes Model Derived from Induced Pluripotent Stem Cells.
    Leventoux N; Morimoto S; Imaizumi K; Sato Y; Takahashi S; Mashima K; Ishikawa M; Sonn I; Kondo T; Watanabe H; Okano H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.
    Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA
    J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of astrocyte reactivity promotes neurodegeneration in human pluripotent stem cell models.
    Gomes C; Huang KC; Harkin J; Baker A; Hughes JM; Pan Y; Tutrow K; VanderWall KB; Lavekar SS; Hernandez M; Cummins TR; Canfield SG; Meyer JS
    Stem Cell Reports; 2024 Aug; 19(8):1122-1136. PubMed ID: 39094561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs.
    Halpern M; Brennand KJ; Gregory J
    Neurobiol Dis; 2019 Dec; 132():104562. PubMed ID: 31381978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.
    Zhang X; Hu D; Shang Y; Qi X
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165431. PubMed ID: 30898538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocyte-Neuron Metabolic Crosstalk in Neurodegeneration: A Mitochondrial Perspective.
    Mulica P; Grünewald A; Pereira SL
    Front Endocrinol (Lausanne); 2021; 12():668517. PubMed ID: 34025580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocytes: From the Physiology to the Disease.
    Trujillo-Estrada L; Gomez-Arboledas A; Forner S; Martini AC; Gutierrez A; Baglietto-Vargas D; LaFerla FM
    Curr Alzheimer Res; 2019; 16(8):675-698. PubMed ID: 31470787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytes in Alzheimer's disease.
    Verkhratsky A; Olabarria M; Noristani HN; Yeh CY; Rodriguez JJ
    Neurotherapeutics; 2010 Oct; 7(4):399-412. PubMed ID: 20880504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytic dysfunction: insights on the role in neurodegeneration.
    Rossi D; Volterra A
    Brain Res Bull; 2009 Oct; 80(4-5):224-32. PubMed ID: 19631259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders.
    Kumar M; Nguyen NTP; Milanese M; Bonanno G
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of astrocytes to neuropathology of neurodegenerative diseases.
    Acioglu C; Li L; Elkabes S
    Brain Res; 2021 May; 1758():147291. PubMed ID: 33516810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte-neuron metabolic relationships: for better and for worse.
    Allaman I; Bélanger M; Magistretti PJ
    Trends Neurosci; 2011 Feb; 34(2):76-87. PubMed ID: 21236501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALS, a cellular whodunit on motor neuron degeneration.
    Karagiannis P; Inoue H
    Mol Cell Neurosci; 2020 Sep; 107():103524. PubMed ID: 32629110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Disease: astrocytes in neurodegenerative disease.
    Maragakis NJ; Rothstein JD
    Nat Clin Pract Neurol; 2006 Dec; 2(12):679-89. PubMed ID: 17117171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes.
    Santiago-Balmaseda A; Aguirre-Orozco A; Valenzuela-Arzeta IE; Villegas-Rojas MM; Pérez-Segura I; Jiménez-Barrios N; Hurtado-Robles E; Rodríguez-Hernández LD; Rivera-German ER; Guerra-Crespo M; Martinez-Fong D; Ledesma-Alonso C; Diaz-Cintra S; Soto-Rojas LO
    Cells; 2024 May; 13(11):. PubMed ID: 38891053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration.
    Vardjan N; Verkhratsky A; Zorec R
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis.
    Smethurst P; Risse E; Tyzack GE; Mitchell JS; Taha DM; Chen YR; Newcombe J; Collinge J; Sidle K; Patani R
    Brain; 2020 Feb; 143(2):430-440. PubMed ID: 32040555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glia in Neurodegeneration: The Housekeeper, the Defender and the Perpetrator.
    Sheeler C; Rosa JG; Ferro A; McAdams B; Borgenheimer E; Cvetanovic M
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and immune dysfunction of glia in neurodegenerative disorders: Focus on iPSC models.
    Rõlova T; Lehtonen Š; Goldsteins G; Kettunen P; Koistinaho J
    Stem Cells; 2021 Mar; 39(3):256-265. PubMed ID: 33270954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.